PEA0077 In silico prediction of Human Leukocytes Antigen (HLA) class II binding Hepatitis B Virus (HBV) peptides in BotswanaE-Poster BU Poster exhibitionA30
PEA0088 Predictors of sensory neuropathy and neuropathic symptom worsening after 12 years in aging people with HIVE-Poster BU Poster exhibitionA31
PEA0078 A challenge for HIV treatment: The long time to immune recovery of people living with HIV under antiretroviral therapy. A longitudinal study in a big state of BrazilE-posterA32
PEA0079 Diagnostic accuracy of Pan Degenerative Amplification and Adaption assay for drug resistance mutations among HIV-1 infected adolescents failing ART therapy in Zimbabwe: Role of a point mutation assayE-posterA33
PEA0080 A98S mutation/polymorphism on RT region of HIV-1 subtype C isolates: Possible impact of geographical variation on drug resistanceE-posterA33
PEA0081 Improving geno2pheno[coreceptor] to predict the tropism of clinical HIV-1 CRF01_AE samplesE-posterA33
PEA0082 Integrated Point-Of-Care (POC) diagnostics for TB and HIV (EID/VL) In Cameroon ' Early implementation results across five GeneXpert (GX) testing sitesE-posterA33
PEA0083 Dose adjustment of doravirine mitigates the pharmacokinetic interaction with the moderate CYP3A inducer, rifabutinE-posterA34
PEA0084 Effects of INSTI and other ARV combinations on folate distribution via folate transporters: Implications for neural tube defectsE-posterA34
PEA0085 Targeting tipranavir to mesenteric lymph nodes (MLNs) for improved treatment of HIV/AIDSE-posterA34
seek-warrow-warrow-eseek-e91 - 100 of 2297 items